Search | New Scientist

IBM to investigate role of microbiome in autoimmune disorders

23 August 2017

A project launched by tech firm IBM plans to analyse millions of bacterial genes, in an effort to understand what causes type 1 diabetes and Crohn's disease

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Subject

Section

Type

Topics

Issue

Premium

IBM to investigate role of microbiome in autoimmune disorders

Sign up to our weekly newsletter